nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—CYP3A4—Estropipate—osteoporosis	0.122	0.181	CbGbCtD
Sufentanil—CYP3A4—Calcitriol—osteoporosis	0.122	0.181	CbGbCtD
Sufentanil—CYP3A4—Ergocalciferol—osteoporosis	0.0974	0.145	CbGbCtD
Sufentanil—CYP3A4—Raloxifene—osteoporosis	0.0813	0.121	CbGbCtD
Sufentanil—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0785	0.117	CbGbCtD
Sufentanil—CYP3A4—Cholecalciferol—osteoporosis	0.0627	0.0934	CbGbCtD
Sufentanil—CYP3A4—Conjugated Estrogens—osteoporosis	0.0576	0.0858	CbGbCtD
Sufentanil—CYP3A4—Estradiol—osteoporosis	0.0506	0.0753	CbGbCtD
Sufentanil—Cardiac arrest—Calcium Acetate—osteoporosis	0.00731	0.0224	CcSEcCtD
Sufentanil—Injection site pain—Ibandronate—osteoporosis	0.00707	0.0216	CcSEcCtD
Sufentanil—Bradycardia—Calcium Acetate—osteoporosis	0.00542	0.0166	CcSEcCtD
Sufentanil—Arrhythmia—Calcium Acetate—osteoporosis	0.00475	0.0145	CcSEcCtD
Sufentanil—Urinary retention—Ibandronate—osteoporosis	0.00398	0.0122	CcSEcCtD
Sufentanil—Confusional state—Calcium Acetate—osteoporosis	0.00381	0.0117	CcSEcCtD
Sufentanil—Bronchospasm—Ibandronate—osteoporosis	0.00356	0.0109	CcSEcCtD
Sufentanil—Hypertension—Ergocalciferol—osteoporosis	0.00353	0.0108	CcSEcCtD
Sufentanil—Hypotension—Calcium Acetate—osteoporosis	0.00353	0.0108	CcSEcCtD
Sufentanil—Feeling abnormal—Calcium Acetate—osteoporosis	0.00311	0.00953	CcSEcCtD
Sufentanil—Urinary incontinence—Estradiol—osteoporosis	0.00307	0.0094	CcSEcCtD
Sufentanil—Erythema—Etidronic acid—osteoporosis	0.00304	0.0093	CcSEcCtD
Sufentanil—Urinary tract disorder—Raloxifene—osteoporosis	0.00289	0.00884	CcSEcCtD
Sufentanil—Urethral disorder—Raloxifene—osteoporosis	0.00287	0.00877	CcSEcCtD
Sufentanil—Urinary tract disorder—Ibandronate—osteoporosis	0.00286	0.00875	CcSEcCtD
Sufentanil—Urethral disorder—Ibandronate—osteoporosis	0.00284	0.00869	CcSEcCtD
Sufentanil—Bronchospasm—Pamidronate—osteoporosis	0.00279	0.00853	CcSEcCtD
Sufentanil—Hypersensitivity—Calcium Acetate—osteoporosis	0.00278	0.00852	CcSEcCtD
Sufentanil—Pruritus—Calcium Acetate—osteoporosis	0.00267	0.00818	CcSEcCtD
Sufentanil—Erythema—Estropipate—osteoporosis	0.00263	0.00804	CcSEcCtD
Sufentanil—Chills—Ibandronate—osteoporosis	0.0026	0.00795	CcSEcCtD
Sufentanil—Erythema—Alendronate—osteoporosis	0.00259	0.00792	CcSEcCtD
Sufentanil—Bronchospasm—Zoledronate—osteoporosis	0.00255	0.00779	CcSEcCtD
Sufentanil—Arrhythmia—Calcitriol—osteoporosis	0.00253	0.00775	CcSEcCtD
Sufentanil—Erythema—Ibandronate—osteoporosis	0.00252	0.00771	CcSEcCtD
Sufentanil—Confusional state—Etidronic acid—osteoporosis	0.0025	0.00765	CcSEcCtD
Sufentanil—Dizziness—Calcium Acetate—osteoporosis	0.0025	0.00764	CcSEcCtD
Sufentanil—Erythema—Calcitriol—osteoporosis	0.00247	0.00755	CcSEcCtD
Sufentanil—Bronchospasm—Conjugated Estrogens—osteoporosis	0.00245	0.0075	CcSEcCtD
Sufentanil—Urinary tract disorder—Ethinyl Estradiol—osteoporosis	0.00242	0.0074	CcSEcCtD
Sufentanil—Vomiting—Calcium Acetate—osteoporosis	0.0024	0.00735	CcSEcCtD
Sufentanil—Urethral disorder—Ethinyl Estradiol—osteoporosis	0.0024	0.00734	CcSEcCtD
Sufentanil—Urinary tract disorder—Risedronate—osteoporosis	0.00236	0.00721	CcSEcCtD
Sufentanil—Urethral disorder—Risedronate—osteoporosis	0.00234	0.00716	CcSEcCtD
Sufentanil—Nausea—Calcium Acetate—osteoporosis	0.00224	0.00687	CcSEcCtD
Sufentanil—Urinary tract disorder—Pamidronate—osteoporosis	0.00224	0.00686	CcSEcCtD
Sufentanil—Urethral disorder—Pamidronate—osteoporosis	0.00222	0.00681	CcSEcCtD
Sufentanil—Hypertension—Ibandronate—osteoporosis	0.00218	0.00666	CcSEcCtD
Sufentanil—Anaphylactic shock—Estropipate—osteoporosis	0.00215	0.00657	CcSEcCtD
Sufentanil—Arrhythmia—Risedronate—osteoporosis	0.00213	0.00652	CcSEcCtD
Sufentanil—Hypertension—Calcitriol—osteoporosis	0.00213	0.00652	CcSEcCtD
Sufentanil—Bradycardia—Zoledronate—osteoporosis	0.00211	0.00646	CcSEcCtD
Sufentanil—Anaphylactic shock—Ibandronate—osteoporosis	0.00206	0.0063	CcSEcCtD
Sufentanil—Urinary tract disorder—Zoledronate—osteoporosis	0.00205	0.00626	CcSEcCtD
Sufentanil—Feeling abnormal—Etidronic acid—osteoporosis	0.00204	0.00625	CcSEcCtD
Sufentanil—Chills—Pamidronate—osteoporosis	0.00204	0.00623	CcSEcCtD
Sufentanil—Urethral disorder—Zoledronate—osteoporosis	0.00203	0.00622	CcSEcCtD
Sufentanil—Anaphylactic shock—Calcitriol—osteoporosis	0.00201	0.00616	CcSEcCtD
Sufentanil—Nausea—Ergocalciferol—osteoporosis	0.00198	0.00606	CcSEcCtD
Sufentanil—Erythema—Pamidronate—osteoporosis	0.00198	0.00604	CcSEcCtD
Sufentanil—Bronchospasm—Estradiol—osteoporosis	0.00196	0.00601	CcSEcCtD
Sufentanil—Somnolence—Estropipate—osteoporosis	0.00191	0.00584	CcSEcCtD
Sufentanil—Chills—Zoledronate—osteoporosis	0.00186	0.00569	CcSEcCtD
Sufentanil—Arrhythmia—Zoledronate—osteoporosis	0.00185	0.00566	CcSEcCtD
Sufentanil—Hypersensitivity—Etidronic acid—osteoporosis	0.00183	0.00559	CcSEcCtD
Sufentanil—Erythema—Zoledronate—osteoporosis	0.0018	0.00552	CcSEcCtD
Sufentanil—Hypertension—Risedronate—osteoporosis	0.00179	0.00549	CcSEcCtD
Sufentanil—Somnolence—Calcitriol—osteoporosis	0.00179	0.00548	CcSEcCtD
Sufentanil—Arrhythmia—Conjugated Estrogens—osteoporosis	0.00178	0.00545	CcSEcCtD
Sufentanil—Pruritus—Etidronic acid—osteoporosis	0.00176	0.00537	CcSEcCtD
Sufentanil—Feeling abnormal—Alendronate—osteoporosis	0.00174	0.00533	CcSEcCtD
Sufentanil—Erythema—Conjugated Estrogens—osteoporosis	0.00174	0.00532	CcSEcCtD
Sufentanil—Hypertension—Pamidronate—osteoporosis	0.00171	0.00522	CcSEcCtD
Sufentanil—Body temperature increased—Estropipate—osteoporosis	0.0017	0.00519	CcSEcCtD
Sufentanil—Feeling abnormal—Ibandronate—osteoporosis	0.0017	0.00519	CcSEcCtD
Sufentanil—Body temperature increased—Alendronate—osteoporosis	0.00167	0.00511	CcSEcCtD
Sufentanil—Body temperature increased—Raloxifene—osteoporosis	0.00164	0.00503	CcSEcCtD
Sufentanil—Body temperature increased—Ibandronate—osteoporosis	0.00163	0.00498	CcSEcCtD
Sufentanil—Confusional state—Pamidronate—osteoporosis	0.00163	0.00497	CcSEcCtD
Sufentanil—Anaphylactic shock—Pamidronate—osteoporosis	0.00161	0.00493	CcSEcCtD
Sufentanil—Body temperature increased—Calcitriol—osteoporosis	0.00159	0.00487	CcSEcCtD
Sufentanil—Hypersensitivity—Estropipate—osteoporosis	0.00158	0.00484	CcSEcCtD
Sufentanil—Urinary tract disorder—Estradiol—osteoporosis	0.00158	0.00483	CcSEcCtD
Sufentanil—Vomiting—Etidronic acid—osteoporosis	0.00158	0.00482	CcSEcCtD
Sufentanil—Tachycardia—Pamidronate—osteoporosis	0.00157	0.00481	CcSEcCtD
Sufentanil—Urethral disorder—Estradiol—osteoporosis	0.00157	0.00479	CcSEcCtD
Sufentanil—Rash—Etidronic acid—osteoporosis	0.00156	0.00478	CcSEcCtD
Sufentanil—Dermatitis—Etidronic acid—osteoporosis	0.00156	0.00478	CcSEcCtD
Sufentanil—Hypertension—Zoledronate—osteoporosis	0.00156	0.00477	CcSEcCtD
Sufentanil—Hypersensitivity—Alendronate—osteoporosis	0.00156	0.00476	CcSEcCtD
Sufentanil—Headache—Etidronic acid—osteoporosis	0.00155	0.00475	CcSEcCtD
Sufentanil—Pruritus—Estropipate—osteoporosis	0.00152	0.00464	CcSEcCtD
Sufentanil—Hypersensitivity—Ibandronate—osteoporosis	0.00152	0.00464	CcSEcCtD
Sufentanil—Hypotension—Pamidronate—osteoporosis	0.00151	0.00461	CcSEcCtD
Sufentanil—Pruritus—Alendronate—osteoporosis	0.0015	0.00457	CcSEcCtD
Sufentanil—Confusional state—Zoledronate—osteoporosis	0.00149	0.00454	CcSEcCtD
Sufentanil—Hypersensitivity—Calcitriol—osteoporosis	0.00148	0.00454	CcSEcCtD
Sufentanil—Nausea—Etidronic acid—osteoporosis	0.00147	0.00451	CcSEcCtD
Sufentanil—Anaphylactic shock—Zoledronate—osteoporosis	0.00147	0.00451	CcSEcCtD
Sufentanil—Pruritus—Ibandronate—osteoporosis	0.00146	0.00445	CcSEcCtD
Sufentanil—Tachycardia—Zoledronate—osteoporosis	0.00144	0.0044	CcSEcCtD
Sufentanil—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00143	0.00439	CcSEcCtD
Sufentanil—Chills—Estradiol—osteoporosis	0.00143	0.00438	CcSEcCtD
Sufentanil—Somnolence—Pamidronate—osteoporosis	0.00143	0.00438	CcSEcCtD
Sufentanil—Pruritus—Calcitriol—osteoporosis	0.00143	0.00436	CcSEcCtD
Sufentanil—Dizziness—Estropipate—osteoporosis	0.00142	0.00434	CcSEcCtD
Sufentanil—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00142	0.00434	CcSEcCtD
Sufentanil—Dizziness—Alendronate—osteoporosis	0.0014	0.00428	CcSEcCtD
Sufentanil—Erythema—Estradiol—osteoporosis	0.00139	0.00425	CcSEcCtD
Sufentanil—Tachycardia—Conjugated Estrogens—osteoporosis	0.00138	0.00423	CcSEcCtD
Sufentanil—Hypotension—Zoledronate—osteoporosis	0.00138	0.00421	CcSEcCtD
Sufentanil—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00138	0.00421	CcSEcCtD
Sufentanil—Dizziness—Raloxifene—osteoporosis	0.00137	0.00421	CcSEcCtD
Sufentanil—Vomiting—Estropipate—osteoporosis	0.00136	0.00417	CcSEcCtD
Sufentanil—Dizziness—Ibandronate—osteoporosis	0.00136	0.00416	CcSEcCtD
Sufentanil—Rash—Estropipate—osteoporosis	0.00135	0.00414	CcSEcCtD
Sufentanil—Dermatitis—Estropipate—osteoporosis	0.00135	0.00414	CcSEcCtD
Sufentanil—Headache—Estropipate—osteoporosis	0.00134	0.00411	CcSEcCtD
Sufentanil—Vomiting—Alendronate—osteoporosis	0.00134	0.00411	CcSEcCtD
Sufentanil—Body temperature increased—Risedronate—osteoporosis	0.00134	0.0041	CcSEcCtD
Sufentanil—Rash—Alendronate—osteoporosis	0.00133	0.00408	CcSEcCtD
Sufentanil—Dermatitis—Alendronate—osteoporosis	0.00133	0.00407	CcSEcCtD
Sufentanil—Feeling abnormal—Pamidronate—osteoporosis	0.00133	0.00406	CcSEcCtD
Sufentanil—Hypotension—Conjugated Estrogens—osteoporosis	0.00133	0.00405	CcSEcCtD
Sufentanil—Headache—Alendronate—osteoporosis	0.00132	0.00405	CcSEcCtD
Sufentanil—Vomiting—Raloxifene—osteoporosis	0.00132	0.00404	CcSEcCtD
Sufentanil—Rash—Raloxifene—osteoporosis	0.00131	0.00401	CcSEcCtD
Sufentanil—Dermatitis—Raloxifene—osteoporosis	0.00131	0.00401	CcSEcCtD
Sufentanil—Somnolence—Zoledronate—osteoporosis	0.00131	0.004	CcSEcCtD
Sufentanil—Vomiting—Ibandronate—osteoporosis	0.00131	0.004	CcSEcCtD
Sufentanil—Headache—Raloxifene—osteoporosis	0.0013	0.00398	CcSEcCtD
Sufentanil—Rash—Ibandronate—osteoporosis	0.0013	0.00397	CcSEcCtD
Sufentanil—Dermatitis—Ibandronate—osteoporosis	0.0013	0.00397	CcSEcCtD
Sufentanil—Headache—Ibandronate—osteoporosis	0.00129	0.00394	CcSEcCtD
Sufentanil—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00128	0.00392	CcSEcCtD
Sufentanil—Vomiting—Calcitriol—osteoporosis	0.00128	0.00392	CcSEcCtD
Sufentanil—Nausea—Estropipate—osteoporosis	0.00127	0.0039	CcSEcCtD
Sufentanil—Body temperature increased—Pamidronate—osteoporosis	0.00127	0.0039	CcSEcCtD
Sufentanil—Rash—Calcitriol—osteoporosis	0.00127	0.00389	CcSEcCtD
Sufentanil—Dermatitis—Calcitriol—osteoporosis	0.00127	0.00388	CcSEcCtD
Sufentanil—Headache—Calcitriol—osteoporosis	0.00126	0.00386	CcSEcCtD
Sufentanil—Somnolence—Conjugated Estrogens—osteoporosis	0.00126	0.00386	CcSEcCtD
Sufentanil—Nausea—Alendronate—osteoporosis	0.00126	0.00384	CcSEcCtD
Sufentanil—Hypersensitivity—Risedronate—osteoporosis	0.00125	0.00382	CcSEcCtD
Sufentanil—Nausea—Raloxifene—osteoporosis	0.00123	0.00378	CcSEcCtD
Sufentanil—Pruritus—Ethinyl Estradiol—osteoporosis	0.00123	0.00376	CcSEcCtD
Sufentanil—Nausea—Ibandronate—osteoporosis	0.00122	0.00374	CcSEcCtD
Sufentanil—Feeling abnormal—Zoledronate—osteoporosis	0.00121	0.00371	CcSEcCtD
Sufentanil—Hypertension—Estradiol—osteoporosis	0.0012	0.00367	CcSEcCtD
Sufentanil—Pruritus—Risedronate—osteoporosis	0.0012	0.00367	CcSEcCtD
Sufentanil—Nausea—Calcitriol—osteoporosis	0.0012	0.00366	CcSEcCtD
Sufentanil—Hypersensitivity—Pamidronate—osteoporosis	0.00119	0.00363	CcSEcCtD
Sufentanil—Body temperature increased—Zoledronate—osteoporosis	0.00116	0.00356	CcSEcCtD
Sufentanil—Dizziness—Ethinyl Estradiol—osteoporosis	0.00115	0.00352	CcSEcCtD
Sufentanil—Confusional state—Estradiol—osteoporosis	0.00114	0.0035	CcSEcCtD
Sufentanil—Pruritus—Pamidronate—osteoporosis	0.00114	0.00349	CcSEcCtD
Sufentanil—Anaphylactic shock—Estradiol—osteoporosis	0.00114	0.00347	CcSEcCtD
Sufentanil—Dizziness—Risedronate—osteoporosis	0.00112	0.00343	CcSEcCtD
Sufentanil—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00112	0.00343	CcSEcCtD
Sufentanil—Tachycardia—Estradiol—osteoporosis	0.00111	0.00339	CcSEcCtD
Sufentanil—Vomiting—Ethinyl Estradiol—osteoporosis	0.00111	0.00338	CcSEcCtD
Sufentanil—Rash—Ethinyl Estradiol—osteoporosis	0.0011	0.00336	CcSEcCtD
Sufentanil—Dermatitis—Ethinyl Estradiol—osteoporosis	0.0011	0.00335	CcSEcCtD
Sufentanil—Headache—Ethinyl Estradiol—osteoporosis	0.00109	0.00333	CcSEcCtD
Sufentanil—Hypersensitivity—Zoledronate—osteoporosis	0.00109	0.00332	CcSEcCtD
Sufentanil—Vomiting—Risedronate—osteoporosis	0.00108	0.0033	CcSEcCtD
Sufentanil—Rash—Risedronate—osteoporosis	0.00107	0.00327	CcSEcCtD
Sufentanil—Dermatitis—Risedronate—osteoporosis	0.00107	0.00327	CcSEcCtD
Sufentanil—Dizziness—Pamidronate—osteoporosis	0.00107	0.00326	CcSEcCtD
Sufentanil—Headache—Risedronate—osteoporosis	0.00106	0.00325	CcSEcCtD
Sufentanil—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00104	0.0032	CcSEcCtD
Sufentanil—Pruritus—Zoledronate—osteoporosis	0.00104	0.00319	CcSEcCtD
Sufentanil—Nausea—Ethinyl Estradiol—osteoporosis	0.00103	0.00316	CcSEcCtD
Sufentanil—Vomiting—Pamidronate—osteoporosis	0.00103	0.00314	CcSEcCtD
Sufentanil—Rash—Pamidronate—osteoporosis	0.00102	0.00311	CcSEcCtD
Sufentanil—Dermatitis—Pamidronate—osteoporosis	0.00102	0.00311	CcSEcCtD
Sufentanil—Headache—Pamidronate—osteoporosis	0.00101	0.00309	CcSEcCtD
Sufentanil—Somnolence—Estradiol—osteoporosis	0.00101	0.00309	CcSEcCtD
Sufentanil—Nausea—Risedronate—osteoporosis	0.00101	0.00308	CcSEcCtD
Sufentanil—Pruritus—Conjugated Estrogens—osteoporosis	0.001	0.00307	CcSEcCtD
Sufentanil—Dizziness—Zoledronate—osteoporosis	0.000974	0.00298	CcSEcCtD
Sufentanil—Nausea—Pamidronate—osteoporosis	0.000958	0.00293	CcSEcCtD
Sufentanil—Dizziness—Conjugated Estrogens—osteoporosis	0.000938	0.00287	CcSEcCtD
Sufentanil—Vomiting—Zoledronate—osteoporosis	0.000936	0.00286	CcSEcCtD
Sufentanil—Feeling abnormal—Estradiol—osteoporosis	0.000935	0.00286	CcSEcCtD
Sufentanil—Rash—Zoledronate—osteoporosis	0.000929	0.00284	CcSEcCtD
Sufentanil—Dermatitis—Zoledronate—osteoporosis	0.000928	0.00284	CcSEcCtD
Sufentanil—Headache—Zoledronate—osteoporosis	0.000923	0.00282	CcSEcCtD
Sufentanil—Vomiting—Conjugated Estrogens—osteoporosis	0.000902	0.00276	CcSEcCtD
Sufentanil—Body temperature increased—Estradiol—osteoporosis	0.000897	0.00274	CcSEcCtD
Sufentanil—Rash—Conjugated Estrogens—osteoporosis	0.000894	0.00274	CcSEcCtD
Sufentanil—Dermatitis—Conjugated Estrogens—osteoporosis	0.000893	0.00273	CcSEcCtD
Sufentanil—Headache—Conjugated Estrogens—osteoporosis	0.000888	0.00272	CcSEcCtD
Sufentanil—Nausea—Zoledronate—osteoporosis	0.000875	0.00268	CcSEcCtD
Sufentanil—Nausea—Conjugated Estrogens—osteoporosis	0.000842	0.00258	CcSEcCtD
Sufentanil—Hypersensitivity—Estradiol—osteoporosis	0.000836	0.00256	CcSEcCtD
Sufentanil—Pruritus—Estradiol—osteoporosis	0.000803	0.00246	CcSEcCtD
Sufentanil—Dizziness—Estradiol—osteoporosis	0.000751	0.0023	CcSEcCtD
Sufentanil—Vomiting—Estradiol—osteoporosis	0.000722	0.00221	CcSEcCtD
Sufentanil—Rash—Estradiol—osteoporosis	0.000716	0.00219	CcSEcCtD
Sufentanil—Dermatitis—Estradiol—osteoporosis	0.000715	0.00219	CcSEcCtD
Sufentanil—Headache—Estradiol—osteoporosis	0.000711	0.00217	CcSEcCtD
Sufentanil—Nausea—Estradiol—osteoporosis	0.000674	0.00206	CcSEcCtD
Sufentanil—OPRM1—Opioid Signalling—ADCY5—osteoporosis	1.64e-05	0.0108	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—CNR2—osteoporosis	1.56e-05	0.0103	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CALCR—osteoporosis	1.56e-05	0.0103	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—PTH1R—osteoporosis	1.56e-05	0.0103	CbGpPWpGaD
Sufentanil—OPRM1—IL4-mediated signaling events—IRS1—osteoporosis	1.55e-05	0.0102	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	1.44e-05	0.00952	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	1.41e-05	0.0093	CbGpPWpGaD
Sufentanil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	1.41e-05	0.00926	CbGpPWpGaD
Sufentanil—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	1.39e-05	0.00914	CbGpPWpGaD
Sufentanil—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	1.33e-05	0.00873	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—CNR2—osteoporosis	1.32e-05	0.00867	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	1.24e-05	0.00815	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	1.22e-05	0.00804	CbGpPWpGaD
Sufentanil—OPRM1—Opioid Signalling—POMC—osteoporosis	1.21e-05	0.00796	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—PTH1R—osteoporosis	1.19e-05	0.00782	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CALCR—osteoporosis	1.19e-05	0.00782	CbGpPWpGaD
Sufentanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	1.14e-05	0.00751	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—PTH—osteoporosis	1.1e-05	0.00727	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CALCR—osteoporosis	1.08e-05	0.0071	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PTH1R—osteoporosis	1.08e-05	0.0071	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CNR2—osteoporosis	1.07e-05	0.00708	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	1.05e-05	0.00689	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CALCR—osteoporosis	1.04e-05	0.00685	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PTH1R—osteoporosis	1.04e-05	0.00685	CbGpPWpGaD
Sufentanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	1.02e-05	0.0067	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—WNT1—osteoporosis	1.01e-05	0.00666	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—PTH—osteoporosis	9.67e-06	0.00637	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—ADCY5—osteoporosis	9.45e-06	0.00623	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PTH1R—osteoporosis	9.45e-06	0.00622	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CALCR—osteoporosis	9.45e-06	0.00622	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—MGLL—osteoporosis	9.43e-06	0.00621	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CNR2—osteoporosis	9.43e-06	0.00621	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—PTHLH—osteoporosis	9.14e-06	0.00602	CbGpPWpGaD
Sufentanil—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	9.14e-06	0.00602	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—WNT1—osteoporosis	8.86e-06	0.00584	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CALCR—osteoporosis	8.79e-06	0.00579	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PTH1R—osteoporosis	8.79e-06	0.00579	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—MGLL—osteoporosis	8.56e-06	0.00564	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—ADCY5—osteoporosis	8.29e-06	0.00546	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—MGLL—osteoporosis	8.27e-06	0.00545	CbGpPWpGaD
Sufentanil—OPRD1—Peptide ligand-binding receptors—POMC—osteoporosis	8.24e-06	0.00543	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—IL1B—osteoporosis	8.24e-06	0.00543	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—PTH—osteoporosis	8.17e-06	0.00539	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CALCA—osteoporosis	8.05e-06	0.0053	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—PTHLH—osteoporosis	8.01e-06	0.00528	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PTH1R—osteoporosis	7.99e-06	0.00526	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CALCR—osteoporosis	7.99e-06	0.00526	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CNR2—osteoporosis	7.97e-06	0.00525	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—MGLL—osteoporosis	7.51e-06	0.00495	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—WNT1—osteoporosis	7.49e-06	0.00493	CbGpPWpGaD
Sufentanil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	7.39e-06	0.00487	CbGpPWpGaD
Sufentanil—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	7.29e-06	0.0048	CbGpPWpGaD
Sufentanil—OPRK1—Peptide ligand-binding receptors—POMC—osteoporosis	7.23e-06	0.00476	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CALCA—osteoporosis	7.06e-06	0.00465	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SOST—osteoporosis	7.04e-06	0.00464	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—ADCY5—osteoporosis	7.01e-06	0.00462	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—MGLL—osteoporosis	6.99e-06	0.0046	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—POMC—osteoporosis	6.95e-06	0.00458	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—PTHLH—osteoporosis	6.77e-06	0.00446	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—TGFB1—osteoporosis	6.4e-06	0.00422	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CALCR—osteoporosis	6.37e-06	0.00419	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PTH1R—osteoporosis	6.37e-06	0.00419	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—MGLL—osteoporosis	6.34e-06	0.00418	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—PTH—osteoporosis	6.23e-06	0.00411	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SOST—osteoporosis	6.17e-06	0.00407	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—POMC—osteoporosis	6.11e-06	0.00402	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—POMC—osteoporosis	6.1e-06	0.00402	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CNR2—osteoporosis	6.07e-06	0.004	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	6.06e-06	0.00399	CbGpPWpGaD
Sufentanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	5.99e-06	0.00395	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	5.97e-06	0.00393	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CALCA—osteoporosis	5.96e-06	0.00393	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PTH—osteoporosis	5.66e-06	0.00373	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PTH1R—osteoporosis	5.58e-06	0.00368	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CALCR—osteoporosis	5.58e-06	0.00368	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	5.53e-06	0.00364	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CNR2—osteoporosis	5.52e-06	0.00363	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PTH—osteoporosis	5.47e-06	0.0036	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CNR2—osteoporosis	5.33e-06	0.00351	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SOST—osteoporosis	5.22e-06	0.00344	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—WNT1—osteoporosis	5.19e-06	0.00342	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—PTHLH—osteoporosis	5.17e-06	0.0034	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—POMC—osteoporosis	5.15e-06	0.00339	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MGLL—osteoporosis	5.06e-06	0.00333	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PTH—osteoporosis	4.96e-06	0.00327	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—LRP5—osteoporosis	4.94e-06	0.00325	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	4.85e-06	0.00319	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CNR2—osteoporosis	4.84e-06	0.00319	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—IL6—osteoporosis	4.83e-06	0.00318	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—LRP6—osteoporosis	4.72e-06	0.00311	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CALCR—osteoporosis	4.72e-06	0.00311	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PTH1R—osteoporosis	4.72e-06	0.00311	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PTHLH—osteoporosis	4.69e-06	0.00309	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PTH—osteoporosis	4.62e-06	0.00304	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—WNT1—osteoporosis	4.55e-06	0.003	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CALCA—osteoporosis	4.55e-06	0.003	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PTHLH—osteoporosis	4.53e-06	0.00298	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CNR2—osteoporosis	4.5e-06	0.00297	CbGpPWpGaD
Sufentanil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.44e-06	0.00292	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MGLL—osteoporosis	4.43e-06	0.00292	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—LRP5—osteoporosis	4.33e-06	0.00285	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—POMC—osteoporosis	4.21e-06	0.00277	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PTH—osteoporosis	4.2e-06	0.00276	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—LRP6—osteoporosis	4.14e-06	0.00273	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CALCA—osteoporosis	4.13e-06	0.00272	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PTHLH—osteoporosis	4.11e-06	0.00271	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	4.1e-06	0.0027	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CNR2—osteoporosis	4.09e-06	0.00269	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CALCA—osteoporosis	3.99e-06	0.00263	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TLN1—osteoporosis	3.99e-06	0.00263	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—WNT1—osteoporosis	3.84e-06	0.00253	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PTHLH—osteoporosis	3.83e-06	0.00252	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MGLL—osteoporosis	3.75e-06	0.00247	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—POMC—osteoporosis	3.69e-06	0.00243	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—LRP5—osteoporosis	3.66e-06	0.00241	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CALCA—osteoporosis	3.62e-06	0.00239	CbGpPWpGaD
Sufentanil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.6e-06	0.00237	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—LRP6—osteoporosis	3.5e-06	0.0023	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TLN1—osteoporosis	3.5e-06	0.0023	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PTHLH—osteoporosis	3.48e-06	0.00229	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—P4HB—osteoporosis	3.44e-06	0.00226	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CALCA—osteoporosis	3.37e-06	0.00222	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PTH—osteoporosis	3.34e-06	0.0022	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—RAP1A—osteoporosis	3.29e-06	0.00216	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CNR2—osteoporosis	3.26e-06	0.00215	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—ADCY5—osteoporosis	3.23e-06	0.00213	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NFATC1—osteoporosis	3.21e-06	0.00211	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.18e-06	0.0021	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—DKK1—osteoporosis	3.18e-06	0.0021	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.14e-06	0.00207	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—POMC—osteoporosis	3.12e-06	0.00206	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—WNT1—osteoporosis	3.06e-06	0.00202	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CALCA—osteoporosis	3.06e-06	0.00202	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—P4HB—osteoporosis	3.01e-06	0.00199	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FGA—osteoporosis	2.98e-06	0.00196	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TLN1—osteoporosis	2.95e-06	0.00195	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—ADCY5—osteoporosis	2.94e-06	0.00194	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PTH—osteoporosis	2.93e-06	0.00193	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—RAP1A—osteoporosis	2.88e-06	0.0019	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CNR2—osteoporosis	2.86e-06	0.00188	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—ADCY5—osteoporosis	2.84e-06	0.00187	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NFATC1—osteoporosis	2.81e-06	0.00185	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—DKK1—osteoporosis	2.79e-06	0.00184	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PTHLH—osteoporosis	2.77e-06	0.00183	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—BMP2—osteoporosis	2.77e-06	0.00183	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FGB—osteoporosis	2.71e-06	0.00179	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—WNT1—osteoporosis	2.69e-06	0.00177	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PSMA2—osteoporosis	2.62e-06	0.00172	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PSMA5—osteoporosis	2.62e-06	0.00172	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FGA—osteoporosis	2.61e-06	0.00172	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—ADCY5—osteoporosis	2.58e-06	0.0017	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—P4HB—osteoporosis	2.55e-06	0.00168	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PTH—osteoporosis	2.48e-06	0.00163	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CALCA—osteoporosis	2.44e-06	0.00161	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—RAP1A—osteoporosis	2.44e-06	0.0016	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PTHLH—osteoporosis	2.43e-06	0.0016	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—BMP2—osteoporosis	2.43e-06	0.0016	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CNR2—osteoporosis	2.41e-06	0.00159	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—ADCY5—osteoporosis	2.4e-06	0.00158	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—POMC—osteoporosis	2.38e-06	0.00157	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FGB—osteoporosis	2.38e-06	0.00157	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NFATC1—osteoporosis	2.38e-06	0.00157	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—DKK1—osteoporosis	2.36e-06	0.00155	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PSMA5—osteoporosis	2.3e-06	0.00151	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PSMA2—osteoporosis	2.3e-06	0.00151	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—WNT1—osteoporosis	2.27e-06	0.0015	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KL—osteoporosis	2.22e-06	0.00146	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGA—osteoporosis	2.21e-06	0.00146	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—ADCY5—osteoporosis	2.18e-06	0.00143	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—POMC—osteoporosis	2.16e-06	0.00142	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CALCA—osteoporosis	2.14e-06	0.00141	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL6R—osteoporosis	2.11e-06	0.00139	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—POMC—osteoporosis	2.09e-06	0.00137	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PTHLH—osteoporosis	2.05e-06	0.00135	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—BMP2—osteoporosis	2.05e-06	0.00135	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGB—osteoporosis	2.01e-06	0.00132	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KL—osteoporosis	1.94e-06	0.00128	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PSMA5—osteoporosis	1.94e-06	0.00128	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PSMA2—osteoporosis	1.94e-06	0.00128	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—POMC—osteoporosis	1.91e-06	0.00126	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—POMC—osteoporosis	1.89e-06	0.00125	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL6R—osteoporosis	1.85e-06	0.00122	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CALCA—osteoporosis	1.81e-06	0.00119	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PKM—osteoporosis	1.8e-06	0.00119	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—FDPS—osteoporosis	1.8e-06	0.00119	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—POMC—osteoporosis	1.76e-06	0.00116	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ADCY5—osteoporosis	1.74e-06	0.00114	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PGLS—osteoporosis	1.71e-06	0.00113	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPD2—osteoporosis	1.71e-06	0.00113	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SPP1—osteoporosis	1.68e-06	0.00111	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KL—osteoporosis	1.64e-06	0.00108	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—POMC—osteoporosis	1.6e-06	0.00105	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ATIC—osteoporosis	1.56e-06	0.00103	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PNP—osteoporosis	1.56e-06	0.00103	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6R—osteoporosis	1.56e-06	0.00103	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ADCY5—osteoporosis	1.52e-06	0.001	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IRS2—osteoporosis	1.52e-06	0.001	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—LEP—osteoporosis	1.49e-06	0.000979	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SPP1—osteoporosis	1.47e-06	0.00097	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ESR1—osteoporosis	1.42e-06	0.000934	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IRS2—osteoporosis	1.33e-06	0.000877	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CA2—osteoporosis	1.33e-06	0.000876	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—OXCT1—osteoporosis	1.33e-06	0.000876	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IRS1—osteoporosis	1.33e-06	0.000873	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—LEP—osteoporosis	1.3e-06	0.000858	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MGLL—osteoporosis	1.3e-06	0.000853	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ADCY5—osteoporosis	1.29e-06	0.000847	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—POMC—osteoporosis	1.28e-06	0.000841	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6R—osteoporosis	1.25e-06	0.00082	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SPP1—osteoporosis	1.24e-06	0.00082	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ESR1—osteoporosis	1.24e-06	0.000819	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IGF1—osteoporosis	1.23e-06	0.000809	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IRS1—osteoporosis	1.16e-06	0.000766	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IRS2—osteoporosis	1.13e-06	0.000741	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—POMC—osteoporosis	1.12e-06	0.000737	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—IDH2—osteoporosis	1.1e-06	0.000726	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—LEP—osteoporosis	1.1e-06	0.000725	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6R—osteoporosis	1.09e-06	0.000719	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IGF1—osteoporosis	1.08e-06	0.000709	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ESR1—osteoporosis	1.05e-06	0.000693	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.04e-06	0.000682	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ACP5—osteoporosis	1.01e-06	0.000664	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IRS1—osteoporosis	9.82e-07	0.000647	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—POMC—osteoporosis	9.46e-07	0.000623	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL6—osteoporosis	9.39e-07	0.000618	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TPI1—osteoporosis	9.37e-07	0.000617	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6R—osteoporosis	9.23e-07	0.000608	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IGF1—osteoporosis	9.1e-07	0.000599	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—P4HB—osteoporosis	8.81e-07	0.00058	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GAPDH—osteoporosis	8.64e-07	0.000569	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—RAP1A—osteoporosis	8.42e-07	0.000555	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL6—osteoporosis	8.23e-07	0.000542	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MYC—osteoporosis	7.38e-07	0.000486	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TGFB1—osteoporosis	7.36e-07	0.000485	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6—osteoporosis	6.96e-07	0.000458	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ENO1—osteoporosis	6.8e-07	0.000448	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PSMA2—osteoporosis	6.71e-07	0.000442	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PSMA5—osteoporosis	6.71e-07	0.000442	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MYC—osteoporosis	6.47e-07	0.000426	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TGFB1—osteoporosis	6.45e-07	0.000425	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6—osteoporosis	5.55e-07	0.000365	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MYC—osteoporosis	5.47e-07	0.00036	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TGFB1—osteoporosis	5.45e-07	0.000359	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.44e-07	0.000358	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6—osteoporosis	4.86e-07	0.00032	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ADCY5—osteoporosis	4.44e-07	0.000293	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPX1—osteoporosis	4.43e-07	0.000292	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6—osteoporosis	4.11e-07	0.000271	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MTHFR—osteoporosis	4.09e-07	0.000269	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—POMC—osteoporosis	3.27e-07	0.000215	CbGpPWpGaD
